Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1997 1
1999 2
2002 3
2003 1
2004 1
2005 2
2009 1
2012 2
2013 2
2015 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.
Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, Schwarz AJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative. Trzepacz PT, et al. Among authors: tabas l. Alzheimers Dement. 2013 Oct;9(5 Suppl):S95-S104.e1. doi: 10.1016/j.jalz.2012.10.005. Epub 2012 Dec 17. Alzheimers Dement. 2013. PMID: 23253778 Free PMC article.
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.
Witte MM, Foster NL, Fleisher AS, Williams MM, Quaid K, Wasserman M, Hunt G, Roberts JS, Rabinovici GD, Levenson JL, Hake AM, Hunter CA, Van Campen LE, Pontecorvo MJ, Hochstetler HM, Tabas LB, Trzepacz PT. Witte MM, et al. Among authors: tabas lb. Alzheimers Dement (Amst). 2015 Jul 26;1(3):358-67. doi: 10.1016/j.dadm.2015.06.006. eCollection 2015 Sep. Alzheimers Dement (Amst). 2015. PMID: 27239516 Free PMC article.
Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonist.
Bueno AB, Collado I, de Dios A, Domínguez C, Martín JA, Martín LM, Martínez-Grau MA, Montero C, Pedregal C, Catlow J, Coffey DS, Clay MP, Dantzig AH, Lindstrom T, Monn JA, Jiang H, Schoepp DD, Stratford RE, Tabas LB, Tizzano JP, Wright RA, Herin MF. Bueno AB, et al. Among authors: tabas lb. J Med Chem. 2005 Aug 11;48(16):5305-20. doi: 10.1021/jm050235r. J Med Chem. 2005. PMID: 16078848
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
Hazell P, Becker K, Nikkanen EA, Trzepacz PT, Tanaka Y, Tabas L, D'Souza DN, Witcher J, Long A, Ponsler G, Dittmann RW. Hazell P, et al. Among authors: tabas l. Atten Defic Hyperact Disord. 2009 Dec;1(2):201-10. doi: 10.1007/s12402-009-0012-4. Epub 2009 Sep 23. Atten Defic Hyperact Disord. 2009. PMID: 20234828 Free PMC article. Clinical Trial.
18 results